Literature DB >> 16038876

Serotonin transporter polymorphisms affect human blood glucose control.

Miki Yamakawa1, Akiko Fukushima, Keiko Sakuma, Yoshiko Yanagisawa, Yasuo Kagawa.   

Abstract

We measured the effect of nutritional intervention on clinical data, including fasting blood glucose (FBG), and their association with polymorphisms of the serotonin transporter-linked polymorphic region (5-HTTLPR) which might affect adherence. Enrolled in the intervention program were 264 Japanese women not on medication for diabetes, hypercholesterolemia or hypertension. The 5-HTTLPR allele (S and L) frequencies among the subjects differed markedly from those of Caucasians: SS (n = 183), LS (n = 69), and LL (n = 12). The decrease in FBG (DeltaFBG) from the beginning to the end of the program (11 weeks; short-term study), and DeltaFBG from the beginning to a follow-up check performed between 2002 and 2004 (average of 23 years later; long-term study) was calculated. The SS homozygotes of 5-HTTLPR showed larger DeltaFBG (P = 0.01 and P < 0.0001 in the short- and long-term studies, respectively) than DeltaFBG with other genotypes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16038876     DOI: 10.1016/j.bbrc.2005.07.022

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

Review 1.  Genetics of human aggressive behaviour.

Authors:  Ian W Craig; Kelly E Halton
Journal:  Hum Genet       Date:  2009-06-09       Impact factor: 4.132

2.  Detecting drug interactions from adverse-event reports: interaction between paroxetine and pravastatin increases blood glucose levels.

Authors:  N P Tatonetti; J C Denny; S N Murphy; G H Fernald; G Krishnan; V Castro; P Yue; P S Tsao; P S Tsau; I Kohane; D M Roden; R B Altman
Journal:  Clin Pharmacol Ther       Date:  2011-05-25       Impact factor: 6.875

3.  Genetic modulation of the serotonergic pathway: influence on weight reduction and weight maintenance.

Authors:  Dirk Wallmeier; Julia K Winkler; Thomas Fleming; Annika Woehning; Katharina Huennemeyer; Eva Roeder; Peter P Nawroth; Hans-Christoph Friederich; Christian Wolfrum; Jobst-Hendrik Schultz; Gottfried Rudofsky
Journal:  Genes Nutr       Date:  2013-06-25       Impact factor: 5.523

4.  Effects of the serotonin transporter (5-HTTLPR) and α2A-adrenoceptor (C-1291G) genotypes on substance use in children and adolescents: a longitudinal study.

Authors:  Liis Merenäkk; Jarek Mäestu; Niklas Nordquist; Jüri Parik; Lars Oreland; Helle-Mai Loit; Jaanus Harro
Journal:  Psychopharmacology (Berl)       Date:  2010-12-08       Impact factor: 4.530

5.  Association of a serotonin transporter gene (SLC6A4) 5-HTTLPR polymorphism with body mass index categories but not type 2 diabetes mellitus in Mexicans.

Authors:  Valeria Peralta-Leal; Evelia Leal-Ugarte; Juan P Meza-Espinoza; Ingrid P Dávalos-Rodríguez; Anabel Bocanegra-Alonso; Rosa I Acosta-González; Enrique Gonzales; Saraswathy Nair; Jorge Durán-González
Journal:  Genet Mol Biol       Date:  2012-07-26       Impact factor: 1.771

6.  Serotonin and the bone assessment.

Authors:  M Carsote; V Radoi; A Geleriu; A Mihai; D Ferechide; D Opris; D Paun; C Poiana
Journal:  J Med Life       Date:  2014

7.  The serotonin and the bone assessment.

Authors:  M Carsote; V Radoi; A Geleriu; A Mihai; D Ferechide; D Opris; D Paun; C Poiana
Journal:  J Med Life       Date:  2013-06-25

8.  Factors affecting discontinuation of initial treatment with paroxetine in panic disorder and major depressive disorder.

Authors:  Akiko Aoki; Shin Ishiguro; Takashi Watanabe; Mikito Ueda; Yuki Hayashi; Kazufumi Akiyama; Kazuko Kato; Yoshimasa Inoue; Shoko Tsuchimine; Norio Yasui-Furukori; Kazutaka Shimoda
Journal:  Neuropsychiatr Dis Treat       Date:  2014-09-18       Impact factor: 2.570

9.  Metabolic Disturbances in Rat Sublines with Constitutionally Altered Serotonin Homeostasis.

Authors:  Maja Kesić; Petra Baković; Ranko Stojković; Jasminka Štefulj; Lipa Čičin-Šain
Journal:  Int J Mol Sci       Date:  2021-05-20       Impact factor: 5.923

Review 10.  Advances in Medications and Tailoring Treatment for Alcohol Use Disorder.

Authors:  Chamindi Seneviratne; Bankole A Johnson
Journal:  Alcohol Res       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.